US Stock MarketDetailed Quotes

INCY Incyte

Watchlist
  • 66.950
  • +1.510+2.31%
Trading Oct 15 13:34 ET
12.89BMarket Cap163.29P/E (TTM)

Incyte Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Incyte Q3 2024 Estimates Date

Currency：USDOct 29, 2024

Estimate YoY
Revenue
1.08B
+17.12%
EPS
0.94
+23.54%
Analyst Rating
Buy

Oct 15, 2024

Incyte Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 18 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 1.139B--
Oct 29, 20242024/Q3-- / 1.076B--
Jul 30, 20242024/Q21.044B / 1.015B--
Apr 30, 20242024/Q1880.889M / 924.642M--
Feb 13, 20242023/Q41.013B / 1.003B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 1.139B--
Oct 29, 20242024/Q3-- / 1.076B--
Jul 30, 20242024/Q21.044B / 1.015B--
Apr 30, 20242024/Q1880.889M / 924.642M--
Feb 13, 20242023/Q41.013B / 1.003B--

Unlock Free Earnings Estimates

Incyte Earnings Reports

  • Incyte | 10-Q: Q2 2024 Earnings Report

    Jul 30 16:18 ET

  • Incyte | 10-Q: Q1 2024 Earnings Report

    Apr 30 16:58 ET

  • Incyte | 10-K/A: Annual report (Amendment)

    Feb 16 16:08 ET

  • Incyte | 10-K: FY2023 Annual Report

    Feb 13 22:15 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 15, 2024

    Buy

    • Buy

      50.00%

    • Hold

      44.44%

    • Sell

      5.56%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Concept CAR-T Therapy
    CAR-T Therapy
    Intraday+1.06%